l carnitine and metabolism therapy for the treatment of metabolic syndrome cardiovascular disease: Evidence and controversies Frontiers | L–carnitine in metabolic

Its usually administered via subcutaneous injection and has been shown to be effective in lowering HbA1c levels (a measure of long-term blood glucose control) and reducing body weight in clinical trials

Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon. Journal of Orthopaedic Research

Its popularity took off through word of mouth and social media rather than through large clinical trials, and that context matters

This research was funded in part by the Wellcome Trust [218467/Z/19/Z]

The cookies we use do not collect sensitive information without your explicit consent, and we adhere to strict data protection regulations